Literature DB >> 35411219

Role of dietary iron revisited: in metabolism, ferroptosis and pathophysiology of cancer.

Santhi Latha Pandrangi1, Prasanthi Chittineedi1, Rajasekhar Chikati2, Joji Reddy Lingareddy3, Meeravali Nagoor4, Suresh Kumar Ponnada3.   

Abstract

Iron is the most abundant metal in the human body. No independent life forms on earth can survive without iron. However, excess iron is closely associated with carcinogenesis by increasing oxidative stress via its catalytic activity to generate hydroxyl radicals. Therefore, it is speculated that iron might play a dual role in cells, by both stimulating cell growth and causing cell death. Dietary iron is absorbed by the intestinal enterocytes in the form of ferrous ion which forms cLIP. Excess iron stored in the form of Ferritin serves as a reservoir under iron depletion conditions. Ferroptosis, is an iron-dependent non-mutational form of cell death process and is suppressed by iron-binding compounds such as deferoxamine. Blocking transferrin-mediated iron import or recycling of iron-containing storage proteins (i.e., ferritin) also attenuates ferroptosis, consistent with the iron-dependent nature of this process. Unsurprisingly, ferroptosis also plays a role in the development of cancer and maybe a beneficial strategy for anticancer treatment. Different lines of evidence suggest that ferroptosis plays a crucial role in the suppression of tumorigenesis. In this review, we have discussed the pros and cons of iron accumulation, utilization and, its role in cell proliferation, ferroptosis and pathophysiology of cancer. AJCR
Copyright © 2022.

Entities:  

Keywords:  Iron; cancer; cytoplasmic labile iron pool (cLIP); ferroptosis; reactive oxygen species

Year:  2022        PMID: 35411219      PMCID: PMC8984875     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  86 in total

Review 1.  Iron metabolism and its contribution to cancer (Review).

Authors:  Ying Chen; Zhimin Fan; Ye Yang; Chunyan Gu
Journal:  Int J Oncol       Date:  2019-02-20       Impact factor: 5.650

2.  Regulatory effects of ferritin on angiogenesis.

Authors:  Lan G Coffman; Derek Parsonage; Ralph D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-06       Impact factor: 11.205

Review 3.  HIF Inhibitors: Status of Current Clinical Development.

Authors:  Jaleh Fallah; Brian I Rini
Journal:  Curr Oncol Rep       Date:  2019-01-22       Impact factor: 5.075

4.  ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition.

Authors:  Sebastian Doll; Bettina Proneth; Yulia Y Tyurina; Elena Panzilius; Sho Kobayashi; Irina Ingold; Martin Irmler; Johannes Beckers; Michaela Aichler; Axel Walch; Holger Prokisch; Dietrich Trümbach; Gaowei Mao; Feng Qu; Hulya Bayir; Joachim Füllekrug; Christina H Scheel; Wolfgang Wurst; Joel A Schick; Valerian E Kagan; José Pedro Friedmann Angeli; Marcus Conrad
Journal:  Nat Chem Biol       Date:  2016-11-14       Impact factor: 15.040

Review 5.  Roles of the hepcidin-ferroportin axis and iron in cancer.

Authors:  Xian-Ning Wu; Dan Su; Li Wang; Feng-Lei Yu
Journal:  Eur J Cancer Prev       Date:  2014-03       Impact factor: 2.497

6.  Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs).

Authors:  Carole Peyssonnaux; Annelies S Zinkernagel; Reto A Schuepbach; Erinn Rankin; Sophie Vaulont; Volker H Haase; Victor Nizet; Randall S Johnson
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 7.  Role of iron in carcinogenesis: cancer as a ferrotoxic disease.

Authors:  Shinya Toyokuni
Journal:  Cancer Sci       Date:  2008-10-23       Impact factor: 6.716

Review 8.  Iron and reactive oxygen species: friends or foes of cancer cells?

Authors:  Laura M Bystrom; Monica L Guzman; Stefano Rivella
Journal:  Antioxid Redox Signal       Date:  2013-01-15       Impact factor: 8.401

9.  Allosteric inhibition of hypoxia inducible factor-2 with small molecules.

Authors:  Thomas H Scheuermann; Qiming Li; He-Wen Ma; Jason Key; Lei Zhang; Rui Chen; Joseph A Garcia; Jacinth Naidoo; Jamie Longgood; Doug E Frantz; Uttam K Tambar; Kevin H Gardner; Richard K Bruick
Journal:  Nat Chem Biol       Date:  2013-02-24       Impact factor: 15.040

Review 10.  Ferroptosis in Cancer Cell Biology.

Authors:  Christina M Bebber; Fabienne Müller; Laura Prieto Clemente; Josephine Weber; Silvia von Karstedt
Journal:  Cancers (Basel)       Date:  2020-01-09       Impact factor: 6.639

View more
  4 in total

1.  Analyzing the drivers of cancer relapse: hypocalcemia and iron absorption in hormone-dependent female cancers.

Authors:  Prasanthi Chittineedi; Santhi Latha Pandrangi; Ravi Shankar Bellala; Sungey Naynee Sánchez Llaguno; Gooty Jaffer Mohiddin; Juan Alejandro Neira Mosquera; Venkata Madhavi Bellala; Viswa Kalyan Kolli
Journal:  Am J Transl Res       Date:  2022-09-15       Impact factor: 3.940

Review 2.  Role of Lipoproteins in the Pathophysiology of Breast Cancer.

Authors:  Santhi Latha Pandrangi; Prasanthi Chittineedi; Rajasekhar Chikati; Juan Alejandro Neira Mosquera; Sungey Naynee Sánchez Llaguno; Gooty Jaffer Mohiddin; Suseela Lanka; Sphoorthi Shree Chalumuri; Narendra Maddu
Journal:  Membranes (Basel)       Date:  2022-05-19

Review 3.  Role of Intracellular Iron in Switching Apoptosis to Ferroptosis to Target Therapy-Resistant Cancer Stem Cells.

Authors:  Santhi Latha Pandrangi; Prasanthi Chittineedi; Sphoorthi Shree Chalumuri; Avtar Singh Meena; Juan Alejandro Neira Mosquera; Sungey Naynee Sánchez Llaguno; Ramachandra Reddy Pamuru; Gooty Jaffer Mohiddin; Arifullah Mohammad
Journal:  Molecules       Date:  2022-05-07       Impact factor: 4.927

4.  Curcumin-Based β-Diketo Ligands for Ga3+: Thermodynamic Investigation of Potential Metal-Based Drugs.

Authors:  Matteo Mari; Debora Carrozza; Gianluca Malavasi; Ettore Venturi; Giulia Avino; Pier Cesare Capponi; Michele Iori; Sara Rubagotti; Silvia Belluti; Mattia Asti; Erika Ferrari
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.